RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.825
+0.018 (2.18%)
At close: Dec 20, 2024, 4:00 PM
0.850
+0.024 (2.93%)
After-hours: Dec 20, 2024, 5:08 PM EST
RAPT Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -107.49 | -116.8 | -83.84 | -69.2 | -52.89 | -43 | |
| Depreciation & Amortization | 1.24 | 1.22 | 1.05 | 1 | 1.12 | 1.33 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.04 | |
| Loss (Gain) From Sale of Investments | -3.51 | -5.74 | -0.3 | 1.27 | 0.5 | - | |
| Stock-Based Compensation | 19.78 | 17.09 | 11.26 | 9.95 | 8.69 | 2.05 | |
| Other Operating Activities | 2.34 | 1.68 | 2.39 | 0.26 | -0.25 | 0.04 | |
| Change in Accounts Payable | -11.62 | 7.34 | 3.71 | 0.93 | 2.39 | 0.74 | |
| Change in Unearned Revenue | - | - | -1.53 | -3.43 | 0.96 | 4 | |
| Change in Other Net Operating Assets | -1.35 | -1.84 | -3.52 | -1.8 | -1.01 | -0.6 | |
| Operating Cash Flow | -100.61 | -97.05 | -70.77 | -61.03 | -40.49 | -35.47 | |
| Capital Expenditures | -0.19 | -1.13 | -0.85 | -0.76 | -0.4 | -0.89 | |
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0.05 | |
| Investment in Securities | 74.37 | 105.26 | -44.65 | -80.59 | -87.04 | - | |
| Investing Cash Flow | 74.18 | 104.13 | -45.49 | -81.35 | -87.44 | -0.84 | |
| Issuance of Common Stock | 10.2 | 1.45 | 131.18 | 141.48 | 75.46 | 35.52 | |
| Financing Cash Flow | 10.2 | 1.45 | 131.18 | 141.48 | 75.46 | 49.9 | |
| Net Cash Flow | -16.24 | 8.53 | 14.92 | -0.89 | -52.47 | 13.59 | |
| Free Cash Flow | -100.8 | -98.17 | -71.62 | -61.78 | -40.89 | -36.36 | |
| Free Cash Flow Margin | - | - | -4689.98% | -1620.27% | -810.97% | - | |
| Free Cash Flow Per Share | -2.60 | -2.56 | -2.20 | -2.26 | -1.69 | -8.37 | |
| Cash Income Tax Paid | - | - | - | - | 0.99 | 0.66 | |
| Levered Free Cash Flow | -64.91 | -54.19 | -40 | -34.44 | -22.33 | -22.02 | |
| Unlevered Free Cash Flow | -64.91 | -54.19 | -40 | -34.44 | -22.33 | -22.02 | |
| Change in Net Working Capital | 13.95 | -8.04 | -2.15 | 1.38 | -1.52 | -2.75 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.